Erlotinib as standard adjuvant therapy for resectable EGFR...

Translational Lung Cancer Research 2019 / 12 Vol. 8; Iss. S4

Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer

Tanaka, Satomi, Uchino, Junji
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Journal:
Translational Lung Cancer Research
DOI:
10.21037/tlcr.2019.06.05
Date:
December, 2019
File:
PDF, 155 KB
2019
Conversion to is in progress
Conversion to is failed